Novartis AG Adjustments For Reconcile Profit Loss
Novartis AG (NVS) reported Adjustments For Reconcile Profit Loss of $11.23 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForReconcileProfitLoss · last filed 2026-02-04
- Novartis AG adjustments for reconcile profit loss for the quarter ending 2025-06-30 was $2.95B, a 23.08% increase year-over-year.
- Novartis AG adjustments for reconcile profit loss for the quarter ending 2024-06-30 was $2.40B, a 6.51% decline year-over-year.
- Novartis AG adjustments for reconcile profit loss for the quarter ending 2023-06-30 was $2.57B, a 16.14% decline year-over-year.
- Novartis AG adjustments for reconcile profit loss for the quarter ending 2022-06-30 was $3.06B, a 61.11% increase year-over-year.
| Period end | Adjustments For Reconcile Profit Loss 3 month | Adjustments For Reconcile Profit Loss 3 month as first filed | Adjustments For Reconcile Profit Loss 6 month | Adjustments For Reconcile Profit Loss 6 month as first filed | Adjustments For Reconcile Profit Loss 12 month | Adjustments For Reconcile Profit Loss 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $11.23B 20-F · filed 2026-02-04 | |||||
| 2025-06-30 | $2.95B 6-K · filed 2025-07-17 | $5.67B 6-K · filed 2025-07-17 | ||||
| 2024-12-31 | $10.23B 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | $2.40B 6-K · filed 2025-07-17 | $4.90B 6-K · filed 2025-07-17 | ||||
| 2023-12-31 | $10.37B 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | $2.57B 6-K · filed 2024-07-18 | $2.88B 6-K · filed 2023-07-18 | $5.25B 6-K · filed 2024-07-18 | $5.89B 6-K · filed 2023-07-18 | ||
| 2022-12-31 | $10.63B 20-F · filed 2025-01-31 | $11.55B 20-F · filed 2023-02-01 | ||||
| 2022-06-30 | $3.06B 6-K · filed 2023-07-18 | $5.41B 6-K · filed 2023-07-18 | ||||
| 2021-12-31 | -$6.43B 20-F · filed 2024-01-31 | -$5.30B 20-F · filed 2022-02-02 | ||||
| 2021-06-30 | $1.90B 6-K · filed 2022-07-19 | $4.27B 6-K · filed 2022-07-19 | ||||
| 2020-12-31 | $9.88B 20-F/A · filed 2023-05-15 | |||||
| 2020-06-30 | $2.35B 6-K · filed 2021-07-21 | $5.20B 6-K · filed 2021-07-21 | ||||
| 2019-12-31 | $9.12B 20-F · filed 2022-02-02 | |||||
| 2019-06-30 | $2.08B 6-K · filed 2020-07-21 | $4.10B 6-K · filed 2020-07-21 | ||||
| 2018-12-31 | $1.49B 20-F · filed 2021-01-26 | $3.17B 20-F · filed 2019-01-30 | ||||
| 2018-06-30 | -$4.08B 6-K · filed 2019-07-18 | -$3.73B 6-K · filed 2018-07-18 | -$2.62B 6-K · filed 2019-07-18 | -$1.89B 6-K · filed 2018-07-18 | ||
| 2017-12-31 | $5.79B 20-F · filed 2020-01-29 | $7.06B 6-K · filed 2018-01-24 | ||||
| 2017-06-30 | $1.69B 6-K · filed 2018-07-18 | $3.55B 6-K · filed 2018-07-18 | ||||
| 2016-12-31 | $8.44B 20-F · filed 2019-01-30 | |||||
| 2015-12-31 | $9.07B 6-K · filed 2018-01-24 |